| Personalised 3D printed medicines: which techniques and polymers are more successful? AA Konta, M García-Piña, DR Serrano Bioengineering 4 (4), 79, 2017 | 312 | 2017 |
| Technology‐enhanced learning in higher education: How to enhance student engagement through blended learning DR Serrano, MA Dea‐Ayuela, E Gonzalez‐Burgos, A Serrano‐Gil, ... European Journal of Education 54 (2), 273-286, 2019 | 229 | 2019 |
| Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale R Fernández-García, A Lalatsa, L Statts, F Bolás-Fernández, ... International journal of pharmaceutics 573, 118817, 2020 | 160 | 2020 |
| Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles DR Serrano, A Lalatsa, MA Dea-Ayuela, PE Bilbao-Ramos, NL Garrett, ... Molecular pharmaceutics 12 (2), 420-431, 2015 | 121 | 2015 |
| Drug delivery nanosystems for the localized treatment of glioblastoma multiforme L Nam, C Coll, LCS Erthal, C De la Torre, D Serrano, R Martínez-Máñez, ... Materials 11 (5), 779, 2018 | 93 | 2018 |
| New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp HK Ruiz, DR Serrano, MA Dea-Ayuela, PE Bilbao-Ramos, ... International journal of pharmaceutics 473 (1-2), 148-157, 2014 | 85 | 2014 |
| Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations DR Serrano, L Hernández, L Fleire, I González-Alvarez, A Montoya, ... International journal of pharmaceutics 447 (1-2), 38-46, 2013 | 79 | 2013 |
| Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties C Grossjohann, DR Serrano, KJ Paluch, P O’Connell, L Vella-Zarb, ... Journal of pharmaceutical sciences 104 (4), 1385-1398, 2015 | 75 | 2015 |
| Cocrystal habit engineering to improve drug dissolution and alter derived powder properties DR Serrano, P O'Connell, KJ Paluch, D Walsh, AM Healy Journal of Pharmacy and Pharmacology 68 (5), 665-677, 2016 | 69 | 2016 |
| 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms S Ayyoubi, JR Cerda, R Fernández-García, P Knief, A Lalatsa, AM Healy, ... International Journal of Pharmaceutics 597, 120336, 2021 | 67 | 2021 |
| Personalised 3D printed medicines: Optimising material properties for successful passive diffusion loading of filaments for fused deposition modelling of solid dosage forms JR Cerda, T Arifi, S Ayyoubi, P Knief, MP Ballesteros, W Keeble, E Barbu, ... Pharmaceutics 12 (4), 345, 2020 | 63 | 2020 |
| Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting R Fernández-García, E de Pablo, MP Ballesteros, DR Serrano International journal of pharmaceutics 525 (1), 139-148, 2017 | 62 | 2017 |
| Production of cocrystals in an excipient matrix by spray drying D Walsh, DR Serrano, ZA Worku, BA Norris, AM Healy International Journal of Pharmaceutics 536 (1), 467-477, 2018 | 55 | 2018 |
| Engineering of pharmaceutical cocrystals in an excipient matrix: Spray drying versus hot melt extrusion D Walsh, DR Serrano, ZA Worku, AM Madi, P O'Connell, B Twamley, ... International Journal of Pharmaceutics 551 (1-2), 241-256, 2018 | 54 | 2018 |
| Oral fixed-dose combination pharmaceutical products: Industrial manufacturing versus personalized 3D printing R Fernández-García, M Prada, F Bolás-Fernández, MP Ballesteros, ... Pharmaceutical research 37, 1-22, 2020 | 48 | 2020 |
| Designing fast-dissolving orodispersible films of amphotericin B for oropharyngeal candidiasis DR Serrano, R Fernandez-Garcia, M Mele, AM Healy, A Lalatsa Pharmaceutics 11 (8), 369, 2019 | 47 | 2019 |
| Modelling and shadowgraph imaging of cocrystal dissolution and assessment of in vitro antimicrobial activity for sulfadimidine/4-aminosalicylic acid cocrystals DR Serrano, T Persoons, DM D'Arcy, C Galiana, MA Dea-Ayuela, ... European Journal of Pharmaceutical Sciences 89, 125-136, 2016 | 47 | 2016 |
| Lomustine nanoparticles enable both bone marrow sparing and high brain drug levels–a strategy for brain cancer treatments FA Fisusi, A Siew, KW Chooi, O Okubanjo, N Garrett, K Lalatsa, D Serrano, ... Pharmaceutical research 33, 1289-1303, 2016 | 45 | 2016 |
| The influence of CYP2C19 genetic polymorphism on the pharmacokinetics/-pharmacodynamics of proton pump inhibitor-containing Helicobacter pylori treatments D Serrano, S Torrado, S Torrado-Santiago, J P Gisbert Current Drug Metabolism 13 (9), 1303-1312, 2012 | 45 | 2012 |
| Orally bioavailable and effective buparvaquone lipid-based nanomedicines for visceral leishmaniasis L Smith, DR Serrano, M Mauger, F Bolás-Fernández, MA Dea-Ayuela, ... Molecular pharmaceutics 15 (7), 2570-2583, 2018 | 44 | 2018 |
Aikaterini LalatsaReader in Nanomedicines, University of StrathclydeVerified email at strath.ac.uk
